CinCor Plans Baxdrostat Phase III Despite Phase II Miss In Uncontrolled Hypertension

 
• By Joseph Haas
  
High blood pressure
CinCor hopes to advance baxdrostat in hypertension despite Phase II setback • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D